Observational Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Nov 28, 2020; 26(44): 7046-7060
Published online Nov 28, 2020. doi: 10.3748/wjg.v26.i44.7046
Figure 3
Figure 3 Prevalence of nonalcoholic fatty liver disease and significant liver fibrosis. A: Prevalence of nonalcoholic fatty liver disease (NAFLD), severe NAFLD and significant liver fibrosis according to body mass index category; and B: Prevalence of NAFLD according to patients’ characteristics. NAFLD: Nonalcoholic fatty liver disease; ALT: Alanine aminotransferase; HOMA-IR: Homeostasis model for assessment of insulin resistance.